image

The equity team of Erste Asset Management has developed a focused range of equity strategies. Our equity team combines cross-market research with the know-how of our local emerging Europe equity specialists. The satellite strategies developed and managed by our team are at our institutional clients’ disposal in form of mutual funds, special mandates, or individual investment solutions.

"This integrated approach contributes to our ability to offer our clients attractive equity strategies.”

Stepan Mikolasek, Head of Equity

In 2015 our equity management team was restructured. It now contains specialists for industrialised and emerging equities. The investment process in equity management is more strongly focused on fundamental research.

  • Integration of equity specialists from industrialised and emerging economies
  • Combination of quantitative and qualitative models and active title selection

 

Our equity management team cooperates across borders. The know-how of 19 experts from six countries is incorporated in the process regardless of where they are based. This integrated team approach contributes to the development of our active equity selection process and enables us to offer our clients attractive investment solutions.

  • Cross-border, integrated team
  • Local presence in the region
  • Focused range of products

In equity management the investment specialists focus on individual markets and sectors. Among the selected satellite strategies are:

  • Emerging Europe
  • Turkey
  • Biotechnology

Erste Asset Management can be considered a pioneer regarding investments in Eastern Europe. This extensive know-how also contributes to the ESPA STOCK EUROPE EMERGING fund, an equity fund that aims to achieve long-term capital appreciation. The funds' management invests primarily in shares of companies from Eastern Europe, Russia and Turkey.

Please see the legal risk notes at the end of this page.

Our team has managed to gain extensive expertise in the biotechnology sector - the ESPA STOCK BIOTEC invests in the most important biotech companies, primarily in the USA. Equities from the Pacific region and Europe are selectively added to the portfolio.

Please see the legal risk notes at the end of this page.

The investment strategy of the ESPA STOCK ISTANBUL fund is focused on stocks from Turkey and aims at achieving long-term capital appreciation. Currency risks are not hedged.

Please see the legal risk notes at the end of this page.

Contact us

You have questions? We are looking forward to hearing from you.

Risc notes according to Austrian Investment Fund Act of 2011 for ESPA STOCK BIOTEC

ESPA STOCK BIOTEC may exhibit increased volatility due to the composition of its portfolio: i.e. the unit value can be subject to significant fluctuations both upwards and downwards within short periods of time.

 

Risk notes according to Austrian Investment Fund Act of 2011 for ESPA STOCK EUROPE-EMERGING

ESPA STOCK EUROPE-EMERGING may exhibit increased volatility due to the composition of its portfolio: i.e. the unit value can be subject to significant fluctuations both upwards and downwards within short periods of time.
 
ESPA STOCK EUROPE-EMERGING may make significant investments in demand deposits or time deposits with a maximum maturity of 12 months pursuant to section 72 of the 2011 Austrian Investment Fund Act.
 
ESPA STOCK EUROPE-EMERGING may make significant investments in derivatives (including swaps and other OTC derivatives) pursuant to section 73 of the 2011 Austrian Investment Fund Act.

 

Warning notices according to Austrian Investment Fund Act of 2011 for ESPA STOCK ISTANBUL

ESPA STOCK ISTANBUL may be subject to elevated levels of volatility due to its composition, i.e. the fund share price may fluctuate significantly both ways within short periods of time.
 
ESPA STOCK ISTANBUL may invest significant amounts of assets under management in derivative instruments (including swaps and other OTC derivatives) in accordance with sect. 73 of the Austrian Investment Fund Act of 2011.

 

Disclaimer

This document is an advertisement. All data is sourced from ERSTE-SPARINVEST Kapitalanlagegesellschaft m.b.H. and Erste Asset Management GmbH unless indicated otherwise. Our languages of communication are German and English.

The prospectus for UCITS (including any amendments) is published in Amtsblatt zur Wiener Zeitung in accordance with the provisions of the InvFG 2011 in the currently amended version. Information for Investors pursuant to § 21 AIFMG is prepared for the alternative investment funds (AIF) administered by ERSTE-SPARINVEST Kapitalanlagegesellschaft m.b.H. and Erste Asset Management GmbH, pursuant to the provisions of the AIFMG in connection with the InvFG 2011.

The fund prospectus, Information for Investors pursuant to § 21 AIFMG, and the key investor document/KID can be viewed in their latest versions at the  web site www.erste-am.com or obtained in their latest versions free of charge from the domicile of the management company and the domicile of the custodian bank. The exact date of the most recent publication of the fund prospectus, the languages in which the key investor document is available, and any additional locations where the documents can be obtained can be viewed on the web site www.erste-am.com.

This document serves as additional information for our investors and is based on the knowledge of the staff responsible for preparing it at the time of preparation. Our analyses and conclusions are general in nature and do not take into account the individual needs of our investors in terms of earnings, taxation, and risk appetite. Past performance is not a reliable indicator of the future performance of a fund.

Please note that investments in securities entail risks in addition to the opportunities presented here. The value of shares and their earnings can rise and fall. Changes in exchange rates can also have a positive or negative effect on the value of an investment. For this reason, you may receive less than your originally invested amount when you redeem your shares. Persons who are interested in purchasing shares in investment funds are advised to read the current fund prospectus(es) or the Information for Investors pursuant to § 21 AIFMG, especially the risk notices it or they contain, before making an investment decision.

Please consult the corresponding information in the prospectus or Information for Investors pursuant to § 21 AIFMG for restrictions on the sale of fund shares to American citizens. Misprints and errors excepted.